Utilization Evaluation of Human Papilloma Virus Vaccine (GARDASIL®) in Iran; A Cross-Sectional Study.

AuthorFateme Mohammadpouren
AuthorAva Mansourien
AuthorMolouk Hadjibabaieen
Issued Date2020-01-31en
AbstractVaccination against HPV seems to be a good approach for prevention of cervical cancer and genital warts. But in Iran we are confronted with lack of evidence for its cost-effectiveness whereas its consumption is dramatically increasing.en
DOIhttps://doi.org/10.22037/ijpr.2020.1100923en
KeywordIranen
KeywordUtilizationen
KeywordGardasilen
KeywordHuman papilloma virus vaccineen
KeywordGuideline adherenceen
PublisherBrieflandsen
TitleUtilization Evaluation of Human Papilloma Virus Vaccine (GARDASIL®) in Iran; A Cross-Sectional Study.en
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-19-68.pdf
Size:
306.22 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF